Treatment of lupus nephritis.
D001323:Autoantibodies / Q000032:analysis; D003165:Complement System Proteins / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA; D005919:Glomerular Filtration Rate; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D009393:Nephritis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology
D001323:Autoantibodies; D003520:Cyclophosphamide; D003165:Complement System Proteins; D004247:DNA; D011239:Prednisolone